Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/2009
10/22/2009US20090264389 Method of preparing dry powder inhalation compositions
10/22/2009US20090264367 5-cnac as oral delivery agent for parathyroid hormone fragments
10/22/2009US20090264340 Compositions and methods for increasing the oral absorption of antimicrobials
10/22/2009US20090263491 Polylactide Nanoparticles
10/22/2009US20090263490 Microsphere beeswax for mammalian dietary fat mitigation
10/22/2009US20090263489 Analgesic and anti-inflammatory compositions and methods for reducing, preventing or treating pain and inflammation
10/22/2009US20090263488 Pressurised metered dose inhalers containing solutions of beta-2 agonists
10/22/2009US20090263487 Bubble drink provided by bubbling engineering progress
10/22/2009US20090263486 Nanoparticle-stabilized capsule formulation for treatment of inflammation
10/22/2009US20090263485 Targeted hollow gold nanostructures and methods of use
10/22/2009US20090263484 Tissue Engineering Devices and Methods for Luminal Organs
10/22/2009US20090263483 Nanoparticle formulations and uses thereof
10/22/2009US20090263482 Treatment of inflammatory bowel disease with 6-mercaptopurine
10/22/2009US20090263481 Levetiracetam formulations
10/22/2009US20090263480 Taste-masked pharmaceutical compositions prepared by coacervation
10/22/2009US20090263479 Formulations for poorly permeable active pharmaceutical ingredients
10/22/2009US20090263478 Carvedilol forms, compositions, and methods of preparation thereof
10/22/2009US20090263477 Salts of fenofibric acid and pharmaceutical formulations thereof
10/22/2009US20090263476 Composition of Rapid Disintegrating Direct Compression Buccal Tablet
10/22/2009US20090263475 Dexlansoprazole compositions
10/22/2009US20090263474 Methods for Treating Autoimmune Diseases in a Subject and In Vitro Diagnostic Assays
10/22/2009US20090263473 Nanoliposome Using Esterified Lecithin And Method For Preparing The Same, And Composition For Preventing Or Treating Skin Diseases Comprising The Same
10/22/2009US20090263472 Endothelin receptor antagonist derivatives
10/22/2009US20090263471 Controlled Release Pharmaceutical Composition of Venlafaxine Hydrochloride, and Process for Preparation Thereof
10/22/2009US20090263470 Vaccine Compositions Comprising Virosomes and a Saponin Adjuvant
10/22/2009US20090263469 Biguanide-containing liposomes
10/22/2009US20090263468 Methods and compositions for wound healing
10/22/2009US20090263467 Combination drug therapy using orally dissolving film or orally disintegrating tablet dosage forms to treat dry mouth ailments
10/22/2009US20090263466 Herbal composition for treatment of hyperlipidemia and the inhibition of myocardial infarction
10/22/2009US20090263463 Alpha adrenergic receptor agonists for treatment of pain and/or inflammation
10/22/2009US20090263462 Methods for Treating Conditions Such as Dystonia and Post-Stroke Spasticity with Clonidine
10/22/2009US20090263461 Alpha adrenergic receptor agonists for treatment of degenerative disc disease
10/22/2009US20090263460 Medical devices and methods including polymers having biologically active agents therein
10/22/2009US20090263456 Methods and Compositions for Reducing Preventing and Treating Adhesives
10/22/2009US20090263455 Dexamethasone Formulations in a Bioegradable Material
10/22/2009US20090263453 Methods and Compositions for Treating Pain Comprising a Statin
10/22/2009US20090263448 Clonidine Formulation in a Polyorthoester Carrier
10/22/2009US20090263446 Method of making load bearing hydrogel implants
10/22/2009US20090263445 Medical devices comprising spray dried microparticles
10/22/2009US20090263444 Fluocinolone Formulations in a Biodegradable Polymer Carrier
10/22/2009US20090263443 Methods for treating post-operative effects such as spasticity and shivering with clondine
10/22/2009US20090263436 Material primarily for medical, long-term in vivo use, and method for the production thereof
10/22/2009US20090263432 Stable combinations of amlodipine besylate and benazepril hydrochloride
10/22/2009US20090263430 Multilayer Silk Protein Films
10/22/2009US20090263409 Cancer antigen peptide formulations
10/22/2009US20090263335 Use of aerosolized cyclosporine for prevention and treatment of pulmonary disease
10/22/2009US20090263334 Cyclic Glycyl-2-Allyl Proline Improves Cognitive Performance in Impaired Animals
10/22/2009US20090263333 Pharmaceutical compounds and compositions
10/22/2009US20090263327 Minimally invasive physiological function monitoring agents
10/22/2009US20090263319 Methods and compositions for treating postoperative pain comprosing ketorolac
10/22/2009US20090260271 Visible animal scent and dispersion system
10/22/2009DE202009010624U1 Vorrichtung zum Reinigen von Wunden An apparatus for cleaning of wounds
10/22/2009CA2722308A1 Nucleoside derivatives for treatment of caliciviridae infections, including norovirus infections
10/22/2009CA2721649A1 Compositions for the treatment of lice
10/22/2009CA2721586A1 Compositions containing antiviral compounds and methods of using the same
10/22/2009CA2721568A1 An antibody bound synthetic vesicle containing active agent molecules
10/22/2009CA2721554A1 Effects of probiotics on human and animals under environmental or biological changes
10/22/2009CA2721510A1 Methods for treating herpes virus infections
10/22/2009CA2721509A1 Method and pharmaceutical composition for obtaining the plasmatic progesterone levels required for different therapeutic indications
10/22/2009CA2721457A1 Topical combinations comprising an antimycotic agent and an antiviral agent
10/22/2009CA2721335A1 Process for preparing bioabsorbable sheet preparation holding thrombin
10/22/2009CA2721279A1 Steroid nebuliser formulation
10/22/2009CA2721083A1 Compositions comprising weakly basic drugs and controlled-release dosage forms
10/22/2009CA2721019A1 Pharmaceutical compositions of paclitaxel, paclitaxel analogs or paclitaxel conjugates and related methods of preparation and use
10/22/2009CA2720990A1 Alpha and beta adrenergic receptor agonists for treatment of pain and/or inflammation
10/22/2009CA2720849A1 High density compositions containing posaconazole and formulations comprising the same
10/22/2009CA2720845A1 Liquid buffered gdf-5 formulations
10/22/2009CA2720203A1 Osteogenic composition including a complex growth factor/amphiphilic polymer, a soluble cation salt, and an organic substrate
10/22/2009CA2700736A1 Methods and compositions for treating post-operative pain comprising a local anesthetic
10/22/2009CA2700586A1 Clonidine formulations in a biodegradable polymer carrier
10/22/2009CA2700561A1 Medical devices and methods including polymers having biologically active agents therein
10/22/2009CA2700389A1 Methods and compositions for treating post-operative pain comprising clonidine
10/22/2009CA2700262A1 Compositions and methods for treating post-operative pain using clonidine and bupivacaine
10/22/2009CA2700196A1 Method for treating acute pain with a formulated drug depot in combination with a liquid formulation
10/22/2009CA2700002A1 Alpha adrenergic receptor agonists for treatment of pain and/or inflammation
10/21/2009EP2110134A1 Cocoa extract compounds and methods for making and using the same
10/21/2009EP2110131A1 Anti-tumor composition comprising tissue-accumulating chitosan gel
10/21/2009EP2110126A1 Inhalative and instillative use of semi-fluorised alkanes as active ingredient carriers in the intrapulmonary area
10/21/2009EP2110125A1 Transdermal drug administration device
10/21/2009EP2110124A1 Bioavailable Solid Dosage Forms of Metaxalone
10/21/2009EP2109459A1 Archaeal polar lipid aggregates for administration to animals
10/21/2009EP2109451A1 Encapsulated picoplatin
10/21/2009EP2109446A2 Absorbable solid compositions for the topical treatment of oral mucosal disorders
10/21/2009EP2109445A2 Compositions for topical application comprising a peroxide and retinoid
10/21/2009EP2109444A1 Bone growth particles and osteoinductive composition thereof
10/21/2009EP2109443A1 Process for preparation of a stable dispersion of solid amorphous submicron particles in an aqueous medium
10/21/2009EP2109442A2 Ophthalmic compositions containing a synergistic combination of three polymers
10/21/2009EP2026771B1 Microspheres comprising nanocapsules containing a lipophilic drug
10/21/2009EP1863443B1 Rapidly disintegrating dosage form comprising magnesium carbonate heavy
10/21/2009EP1838318B1 Use of oxycodone for treating visceral pain
10/21/2009EP1727524B1 Preparation of lipid coated cefuroxime axetil
10/21/2009EP1667666B9 Pharmaceutical composition containing fenofibrate and method for the preparation thereof
10/21/2009EP1637131B1 Cataplasm base and cataplasm using the same
10/21/2009EP1479300B1 Amino acid powder and process for producing the same
10/21/2009EP1423413B1 Peptidic compounds selectively binding to p-selectin
10/21/2009EP1337239B1 Particles for use in a pharmaceutical composition
10/21/2009EP1169062B1 Heat stable coated colloidal iron oxides
10/21/2009EP1164991B1 Gels formed by the interaction of poly(aldehyde) with various substances
10/21/2009EP1109586B2 External infusion device with remote programming, bolus estimator and/or vibration alarm capabilities
10/21/2009EP0986372B1 Vesicular complexes and methods of making and using the same
1 ... 995 996 997 998 999 1000 1001 1002 1003 1004 1005 1006 1007 1008 1009 1010 1011 1012 1013 1014 1015 ... 2991